Brainomix

Nisha Patel is a 31-year-old new mother who recently suffered a stroke, but thanks to a new initiative that involved the deployment of Brainomix 360 Stroke across all hospitals in Wales, she was quickly diagnosed and promptly treated, enabling her to make a full recovery. Dr Shakeel Ahmad, Lead Stroke Clinician for Wales: "Typically, a potential stroke patient would be taken to have a scan and it would then go for reporting with the doctor simultaneously looking after several other patients. "This standard pathway can take up to 30-60 minutes to analyse the scan, whereas if Brainomix 360 Stroke detects a potential blockage, it sends a ping to a consultant immediately who can then look at the images on their phone. This speeds up the process as they are able to make a decision on treatment there and then." "The AI [Brainomix 360 Stroke] is effectively like lighting a beacon above the patient's head that this person needs urgent attention." Congratulations to Dr Ahmad and his team, who are committed to delivering a best-in-class stroke service for all patients in Wales. These collaborations and stories like Nisha's keep all of us at Brainomix motivated and inspired! #TreatingStrokeTogether #TransformingTreatment NHS Wales Katie Fenton https://lnkd.in/e6j_s8FE

We're proud to see how the University Hospital Ostrava has harnessed the power of Brainomix 360 Stroke over the past five years to revolutionize stroke care. Dr. Ondrej Volny, Neurologist and Vice-Chair for Research at UHO, shares insights into the impact of this technology on patient outcomes and clinical workflows. We're honored to support UHO's mission to provide the highest quality care, and we look forward to continuing our partnership in advancing stroke care. Click the link below to read more about Dr. Volný and UHO ⬇ https://lnkd.in/eW7BhwET #AIinHealthcare #HealthcareInnovation #Brainomix360 #TransformingTreatment

We're headed to #Boston this week for the 8th #IPFSummit, an opportunity to connect with some of the leading voices and pioneers in pulmonary fibrosis. It's been an exciting year for e-Lung and Peter George will be presenting some of the groundbreaking data that underpins our lung imaging biomarkers. Ross Stewart will also be on site to discuss our Life Science partnerships that are helping to drive innovation in this space. #IPF2024 #eLung #pulmonaryfibrosis Hanson Wade Group

🔦 Employee Spotlight: Tomás Rosón, Territory Healthcare Manager (THM) for Southern Europe and LATAM. Tomás expertly navigates multiple continents, regions, and time zones to ensure our customers always have the support they need, forging strong connections built around trust. Click the article below to learn more about Tomás, his journey to becoming a THM, and his enthusiasm for technical sports 🎾 ⬇

🎉 Great news coming from Brainomix and Boehringer Ingelheim who have joined forces 👏 to improve fibrosing lung disease care ➡ https://lnkd.in/e7fM-MGv The project will evaluate the real-world impact of Brainomix's e-Lung 🫁imaging software to improve the identification and access to treatment for people with progressive pulmonary fibrosis in the US. More information in the link above ⬆ #LungDisease #FibrosingLungDisease

🔦 Employee Spotlight: David Balo, Brainomix's First Territory Healthcare Manager David has been a vital part of the Brainomix team for 7 years, significantly contributing to key projects, including the nationwide rollout of Brainomix 360 in Hungary. Discover his favorite projects, what a 'typical' day looks like as a THM, and his passion for craftsmanship 🛠 Learn more about David's journey and contributions in the article below ⬇

Brainomix Partners With Boehringer Ingelheim To Improve Fibrosing Lung Disease Care Learn more & get our take 👇 https://lnkd.in/gMHNNVzp “There is an urgent need to improve the identification of people with fibrosing lung disease. This will enable earlier access to specialist care and the opportunity for faster initiation of treatment, which can slow the worsening of the disease.” — Dr. Michalis Papadakis, CEO and Co-Founder at Brainomix “We believe that Brainomix 360 e-Lung has the potential to revolutionize the diagnostic landscape and thereby enable earlier treatment decisions at a pivotal stage of the patient’s journey.” — Ioannis Sapountzis, Head of Global Therapeutic Areas at Boehringer Ingelheim #lungdisease #partnerships #SoHCNews

🚨 Happening Today! 🚨 Register Now: https://hubs.ly/Q02HV47W0 When is the last time you benchmarked your telestroke program with current best practices? Don’t miss your chance! Join us today for our webinar to uncover the advanced strategies that are reshaping virtual neurology care in 2024 and beyond. 🧠💻 In just a few hours, Dr. Melanie Winningham and Lauren Voltz, RN, will share essential practices and metrics that are transforming telestroke services from good to exceptional. Click to register and join us for a session that promises to be as enlightening as it is essential. https://hubs.ly/Q02HV47W0 #Telestroke #VirtualNeurology #HealthcareInnovation #Webinar #BestPractices

New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks New data was presented this week at the Society of NeuroInterventional Surgery (SNIS) Annual Meeting in Colorado Springs. The latest research, in collaboration with the Mayo Clinic, West Virginia University, and Boston Medical Center (BMC), highlights some of the cutting-edge, AI-enabled technology that has been developed for the Brainomix 360 Stroke platform, representing groundbreaking capabilities that will enable physicians to extract maximal value from universally available non-contrast CT scans across stroke networks. Dr Ansaar Rai, Professor and Chair, Department of Neuroradiology & Neurointerventional Surgery, West Virginia University, said: “The studies presented this week at SNIS highlight the clinical value of the Brainomix 360 Stroke platform, particularly relating to the e-ASPECTS and Triage Stroke algorithms that assess non-contrast CT scans, which are universally available to all stroke centers across the US. The results indicate that these algorithms generate clinically relevant results for frontline stroke physicians that could help them to better manage stroke patients eligible for mechanical thrombectomy across all centers within a network.” Read more about these key studies: ⬇ https://lnkd.in/ekisB6Ad

💥 6 Key Pharma & Digital Health Developments this month>> 💊Daewoong Pharmaceutical is expanding its AI enabled mobiCARE wearable ECG patch into health check up centers in Korea. The patch allows continuous heart monitoring for up to nine days, aiding in detecting hidden heart conditions, enhancing early diagnosis and access to the right treatment 💊Takeda is teaming up with nference to identify AI enabled personalised treatment approaches for patients with inflammatory bowel disease (IBD) The goal is to unlock insights and enable more precise and targeted interventions for the disease, using electronic health record analysis to identify patients who could benefit from specific treatments. 💊AstraZeneca and Bayer participate in $80M Huma investment round. Huma are launching 'Shopify for Digital Health’ a no-code framework designed to allow developers to build and launch custom digital health apps using an array of 'drag-and-drop' widgets and templates 💊Bayer partners with Rad AI to integrate generative AI tools into the Calantic Digital Solution, aiming to streamline radiology workflows and improve efficiency for doctors and hospitals 💊Boehringer Ingelheim expands partnership Brainomix, using AI to improve interstitial lung disease (ILD) care in the US. They will use Brainomix’ 360 e-Lung software (FDA approved in May) to help diagnose and assess ILD patients via CT scans 💊And finally Boehringer Ingelheim will offer its 'Humira rival' at a 92% discount on the digital healthcare platform GoodRx. 👇Link to all articles in comments #DigitalHealth #AI